🔎 Trials Near Me

Beranda › Kanker Hati (Karsinoma Hepatoseluler) › Alabama › Birmingham

Uji klinis Kanker Hati (Karsinoma Hepatoseluler) di Birmingham, AL

8 studi untuk Kanker Hati (Karsinoma Hepatoseluler) mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Menerima pesertaFase 1/2
  • Research Facility, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06726161

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of Alabama At Birmingham Hospital, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06427941

A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Menerima pesertaFase 1/2
  • University of Alabama at Birmingham, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06294548

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Menerima pesertaFase 1
  • University of Alabama at Birmingham, Birmingham
  • University of Alabama at Birmingham, IDS Pharmacy, Birmingham
  • University of Alabama at Birmingham, Birmingham
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05208762

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Menerima peserta
  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Menerima pesertaFase 1/2
  • The Kirklin Clinic of University of Alabama Birmingham Hospital, Birmingham
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT05440708

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Birmingham
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Hati (Karsinoma Hepatoseluler) di kota lain

Studi lain di Birmingham

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.